Request for Covid-19 Impact Assessment of this Report
The United States Human Plasma Products and Derivatives market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Plasma Products and Derivatives market, reaching US$ million by the year 2028. As for the Europe Human Plasma Products and Derivatives landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Human Plasma Products and Derivatives players cover Takeda, CSL, Grifols, and Octapharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Plasma Products and Derivatives market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Coagulation Factor
Immune Globulin
Albumin
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Retail Pharmacy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Plasma Products and Derivatives Market Size 2017-2028
2.1.2 Human Plasma Products and Derivatives Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Human Plasma Products and Derivatives Segment by Type
2.2.1 Coagulation Factor
2.2.2 Immune Globulin
2.2.3 Albumin
2.2.4 Others
2.3 Human Plasma Products and Derivatives Market Size by Type
2.3.1 Human Plasma Products and Derivatives Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Human Plasma Products and Derivatives Market Size Market Share by Type (2017-2022)
2.4 Human Plasma Products and Derivatives Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Human Plasma Products and Derivatives Market Size by Application
2.5.1 Human Plasma Products and Derivatives Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Human Plasma Products and Derivatives Market Size Market Share by Application (2017-2022)
3 Human Plasma Products and Derivatives Market Size by Player
3.1 Human Plasma Products and Derivatives Market Size Market Share by Players
3.1.1 Global Human Plasma Products and Derivatives Revenue by Players (2020-2022)
3.1.2 Global Human Plasma Products and Derivatives Revenue Market Share by Players (2020-2022)
3.2 Global Human Plasma Products and Derivatives Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Human Plasma Products and Derivatives by Regions
4.1 Human Plasma Products and Derivatives Market Size by Regions (2017-2022)
4.2 Americas Human Plasma Products and Derivatives Market Size Growth (2017-2022)
4.3 APAC Human Plasma Products and Derivatives Market Size Growth (2017-2022)
4.4 Europe Human Plasma Products and Derivatives Market Size Growth (2017-2022)
4.5 Middle East & Africa Human Plasma Products and Derivatives Market Size Growth (2017-2022)
5 Americas
5.1 Americas Human Plasma Products and Derivatives Market Size by Country (2017-2022)
5.2 Americas Human Plasma Products and Derivatives Market Size by Type (2017-2022)
5.3 Americas Human Plasma Products and Derivatives Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Plasma Products and Derivatives Market Size by Region (2017-2022)
6.2 APAC Human Plasma Products and Derivatives Market Size by Type (2017-2022)
6.3 APAC Human Plasma Products and Derivatives Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Human Plasma Products and Derivatives by Country (2017-2022)
7.2 Europe Human Plasma Products and Derivatives Market Size by Type (2017-2022)
7.3 Europe Human Plasma Products and Derivatives Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Plasma Products and Derivatives by Region (2017-2022)
8.2 Middle East & Africa Human Plasma Products and Derivatives Market Size by Type (2017-2022)
8.3 Middle East & Africa Human Plasma Products and Derivatives Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Human Plasma Products and Derivatives Market Forecast
10.1 Global Human Plasma Products and Derivatives Forecast by Regions (2023-2028)
10.1.1 Global Human Plasma Products and Derivatives Forecast by Regions (2023-2028)
10.1.2 Americas Human Plasma Products and Derivatives Forecast
10.1.3 APAC Human Plasma Products and Derivatives Forecast
10.1.4 Europe Human Plasma Products and Derivatives Forecast
10.1.5 Middle East & Africa Human Plasma Products and Derivatives Forecast
10.2 Americas Human Plasma Products and Derivatives Forecast by Country (2023-2028)
10.2.1 United States Human Plasma Products and Derivatives Market Forecast
10.2.2 Canada Human Plasma Products and Derivatives Market Forecast
10.2.3 Mexico Human Plasma Products and Derivatives Market Forecast
10.2.4 Brazil Human Plasma Products and Derivatives Market Forecast
10.3 APAC Human Plasma Products and Derivatives Forecast by Region (2023-2028)
10.3.1 China Human Plasma Products and Derivatives Market Forecast
10.3.2 Japan Human Plasma Products and Derivatives Market Forecast
10.3.3 Korea Human Plasma Products and Derivatives Market Forecast
10.3.4 Southeast Asia Human Plasma Products and Derivatives Market Forecast
10.3.5 India Human Plasma Products and Derivatives Market Forecast
10.3.6 Australia Human Plasma Products and Derivatives Market Forecast
10.4 Europe Human Plasma Products and Derivatives Forecast by Country (2023-2028)
10.4.1 Germany Human Plasma Products and Derivatives Market Forecast
10.4.2 France Human Plasma Products and Derivatives Market Forecast
10.4.3 UK Human Plasma Products and Derivatives Market Forecast
10.4.4 Italy Human Plasma Products and Derivatives Market Forecast
10.4.5 Russia Human Plasma Products and Derivatives Market Forecast
10.5 Middle East & Africa Human Plasma Products and Derivatives Forecast by Region (2023-2028)
10.5.1 Egypt Human Plasma Products and Derivatives Market Forecast
10.5.2 South Africa Human Plasma Products and Derivatives Market Forecast
10.5.3 Israel Human Plasma Products and Derivatives Market Forecast
10.5.4 Turkey Human Plasma Products and Derivatives Market Forecast
10.5.5 GCC Countries Human Plasma Products and Derivatives Market Forecast
10.6 Global Human Plasma Products and Derivatives Forecast by Type (2023-2028)
10.7 Global Human Plasma Products and Derivatives Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Human Plasma Products and Derivatives Product Offered
11.1.3 Takeda Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Takeda Main Business Overview
11.1.5 Takeda Latest Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Human Plasma Products and Derivatives Product Offered
11.2.3 CSL Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 CSL Main Business Overview
11.2.5 CSL Latest Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Human Plasma Products and Derivatives Product Offered
11.3.3 Grifols Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Grifols Main Business Overview
11.3.5 Grifols Latest Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Human Plasma Products and Derivatives Product Offered
11.4.3 Octapharma Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Octapharma Main Business Overview
11.4.5 Octapharma Latest Developments
11.5 Kedrion
11.5.1 Kedrion Company Information
11.5.2 Kedrion Human Plasma Products and Derivatives Product Offered
11.5.3 Kedrion Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Kedrion Main Business Overview
11.5.5 Kedrion Latest Developments
11.6 LFB Group
11.6.1 LFB Group Company Information
11.6.2 LFB Group Human Plasma Products and Derivatives Product Offered
11.6.3 LFB Group Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 LFB Group Main Business Overview
11.6.5 LFB Group Latest Developments
11.7 Biotest
11.7.1 Biotest Company Information
11.7.2 Biotest Human Plasma Products and Derivatives Product Offered
11.7.3 Biotest Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Biotest Main Business Overview
11.7.5 Biotest Latest Developments
11.8 BPL
11.8.1 BPL Company Information
11.8.2 BPL Human Plasma Products and Derivatives Product Offered
11.8.3 BPL Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 BPL Main Business Overview
11.8.5 BPL Latest Developments
11.9 RAAS
11.9.1 RAAS Company Information
11.9.2 RAAS Human Plasma Products and Derivatives Product Offered
11.9.3 RAAS Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 RAAS Main Business Overview
11.9.5 RAAS Latest Developments
11.10 CBPO
11.10.1 CBPO Company Information
11.10.2 CBPO Human Plasma Products and Derivatives Product Offered
11.10.3 CBPO Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 CBPO Main Business Overview
11.10.5 CBPO Latest Developments
11.11 Hualan Bio
11.11.1 Hualan Bio Company Information
11.11.2 Hualan Bio Human Plasma Products and Derivatives Product Offered
11.11.3 Hualan Bio Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Hualan Bio Main Business Overview
11.11.5 Hualan Bio Latest Developments
12 Research Findings and Conclusion
Table 1. Human Plasma Products and Derivatives Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Coagulation Factor
Table 3. Major Players of Immune Globulin
Table 4. Major Players of Albumin
Table 5. Major Players of Others
Table 6. Human Plasma Products and Derivatives Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Human Plasma Products and Derivatives Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Human Plasma Products and Derivatives Market Size Market Share by Type (2017-2022)
Table 9. Human Plasma Products and Derivatives Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Human Plasma Products and Derivatives Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Human Plasma Products and Derivatives Market Size Market Share by Application (2017-2022)
Table 12. Global Human Plasma Products and Derivatives Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Human Plasma Products and Derivatives Revenue Market Share by Player (2020-2022)
Table 14. Human Plasma Products and Derivatives Key Players Head office and Products Offered
Table 15. Human Plasma Products and Derivatives Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Human Plasma Products and Derivatives Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Human Plasma Products and Derivatives Market Size Market Share by Regions (2017-2022)
Table 20. Americas Human Plasma Products and Derivatives Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Human Plasma Products and Derivatives Market Size Market Share by Country (2017-2022)
Table 22. Americas Human Plasma Products and Derivatives Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Human Plasma Products and Derivatives Market Size Market Share by Type (2017-2022)
Table 24. Americas Human Plasma Products and Derivatives Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Human Plasma Products and Derivatives Market Size Market Share by Application (2017-2022)
Table 26. APAC Human Plasma Products and Derivatives Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Human Plasma Products and Derivatives Market Size Market Share by Region (2017-2022)
Table 28. APAC Human Plasma Products and Derivatives Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Human Plasma Products and Derivatives Market Size Market Share by Type (2017-2022)
Table 30. APAC Human Plasma Products and Derivatives Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Human Plasma Products and Derivatives Market Size Market Share by Application (2017-2022)
Table 32. Europe Human Plasma Products and Derivatives Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Human Plasma Products and Derivatives Market Size Market Share by Country (2017-2022)
Table 34. Europe Human Plasma Products and Derivatives Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Human Plasma Products and Derivatives Market Size Market Share by Type (2017-2022)
Table 36. Europe Human Plasma Products and Derivatives Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Human Plasma Products and Derivatives Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Human Plasma Products and Derivatives Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Human Plasma Products and Derivatives Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Human Plasma Products and Derivatives Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Human Plasma Products and Derivatives Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Human Plasma Products and Derivatives Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Human Plasma Products and Derivatives Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Human Plasma Products and Derivatives
Table 45. Key Market Challenges & Risks of Human Plasma Products and Derivatives
Table 46. Key Industry Trends of Human Plasma Products and Derivatives
Table 47. Global Human Plasma Products and Derivatives Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Human Plasma Products and Derivatives Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Human Plasma Products and Derivatives Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Human Plasma Products and Derivatives Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Human Plasma Products and Derivatives Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Human Plasma Products and Derivatives Market Size Market Share Forecast by Application (2023-2028)
Table 53. Takeda Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 54. Takeda Human Plasma Products and Derivatives Product Offered
Table 55. Takeda Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Takeda Main Business
Table 57. Takeda Latest Developments
Table 58. CSL Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 59. CSL Human Plasma Products and Derivatives Product Offered
Table 60. CSL Main Business
Table 61. CSL Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. CSL Latest Developments
Table 63. Grifols Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 64. Grifols Human Plasma Products and Derivatives Product Offered
Table 65. Grifols Main Business
Table 66. Grifols Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Grifols Latest Developments
Table 68. Octapharma Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 69. Octapharma Human Plasma Products and Derivatives Product Offered
Table 70. Octapharma Main Business
Table 71. Octapharma Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Octapharma Latest Developments
Table 73. Kedrion Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 74. Kedrion Human Plasma Products and Derivatives Product Offered
Table 75. Kedrion Main Business
Table 76. Kedrion Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Kedrion Latest Developments
Table 78. LFB Group Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 79. LFB Group Human Plasma Products and Derivatives Product Offered
Table 80. LFB Group Main Business
Table 81. LFB Group Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. LFB Group Latest Developments
Table 83. Biotest Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 84. Biotest Human Plasma Products and Derivatives Product Offered
Table 85. Biotest Main Business
Table 86. Biotest Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Biotest Latest Developments
Table 88. BPL Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 89. BPL Human Plasma Products and Derivatives Product Offered
Table 90. BPL Main Business
Table 91. BPL Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. BPL Latest Developments
Table 93. RAAS Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 94. RAAS Human Plasma Products and Derivatives Product Offered
Table 95. RAAS Main Business
Table 96. RAAS Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. RAAS Latest Developments
Table 98. CBPO Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 99. CBPO Human Plasma Products and Derivatives Product Offered
Table 100. CBPO Main Business
Table 101. CBPO Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. CBPO Latest Developments
Table 103. Hualan Bio Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 104. Hualan Bio Human Plasma Products and Derivatives Product Offered
Table 105. Hualan Bio Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. Hualan Bio Main Business
Table 107. Hualan Bio Latest Developments
List of Figures
Figure 1. Human Plasma Products and Derivatives Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Plasma Products and Derivatives Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Human Plasma Products and Derivatives Market Size Market Share by Type in 2021
Figure 7. Human Plasma Products and Derivatives in Hospital
Figure 8. Global Human Plasma Products and Derivatives Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Human Plasma Products and Derivatives in Retail Pharmacy
Figure 10. Global Human Plasma Products and Derivatives Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. Human Plasma Products and Derivatives in Others
Figure 12. Global Human Plasma Products and Derivatives Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Human Plasma Products and Derivatives Market Size Market Share by Application in 2021
Figure 14. Global Human Plasma Products and Derivatives Revenue Market Share by Player in 2021
Figure 15. Global Human Plasma Products and Derivatives Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Human Plasma Products and Derivatives Market Size 2017-2022 ($ Millions)
Figure 17. APAC Human Plasma Products and Derivatives Market Size 2017-2022 ($ Millions)
Figure 18. Europe Human Plasma Products and Derivatives Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Human Plasma Products and Derivatives Market Size 2017-2022 ($ Millions)
Figure 20. Americas Human Plasma Products and Derivatives Value Market Share by Country in 2021
Figure 21. Americas Human Plasma Products and Derivatives Consumption Market Share by Type in 2021
Figure 22. Americas Human Plasma Products and Derivatives Market Size Market Share by Application in 2021
Figure 23. United States Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Human Plasma Products and Derivatives Market Size Market Share by Region in 2021
Figure 28. APAC Human Plasma Products and Derivatives Market Size Market Share by Application in 2021
Figure 29. China Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Human Plasma Products and Derivatives Market Size Market Share by Country in 2021
Figure 36. Europe Human Plasma Products and Derivatives Market Size Market Share by Type in 2021
Figure 37. Europe Human Plasma Products and Derivatives Market Size Market Share by Application in 2021
Figure 38. Germany Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Human Plasma Products and Derivatives Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Human Plasma Products and Derivatives Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Human Plasma Products and Derivatives Market Size Market Share by Application in 2021
Figure 46. Egypt Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Human Plasma Products and Derivatives Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 52. APAC Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 53. Europe Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 55. United States Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 56. Canada Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 59. China Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 60. Japan Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 61. Korea Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 63. India Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 64. Australia Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 65. Germany Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 66. France Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 67. UK Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 68. Italy Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 69. Russia Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 70. Spain Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 73. Israel Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Human Plasma Products and Derivatives Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...